Current Status and Emerging Trends in Global Research on Liposome Therapy for Hepatocellular Carcinoma: A Bibliometric ...
Introduction Hepatocellular carcinoma (HCC) ranks as the fifth most common malignancy worldwide and the second leading cause of cancer-related mortality.1 In 2022, approximately 866,136 new cases and 758,725 deaths from HCC were reported globally, yielding …